J CRAIG VENTER INSTITUTE INC
This organization has already been registered
Someone in your organization has already registered and setup an account. would you like to join their team?Profile owner : m*******e@j**i.o*g
Mission Statement
JCVI is advancing the science of genomics through bold innovations. Our mission is to understand more about the biological world, and to develop unique insights and answers about disease, health, and the environment for the benefit of all.
About This Cause
The J. Craig Venter Institute (JCVI) is a world leader in genomic research with approximately 150 scientists and staff who are bold innovators fearlessly pursuing revolutionary ideas. With a long track-record of creativity and an interdisciplinary approach to genomics, JCVI is committed to accelerating foundational scientific research to drive advances in human health and environmental sustainability. JCVI researchers continue their legacy of success with countless new breakthroughs: the first synthetic cell, the first diploid human genome, discovery of more than 60 million new genes from the Sorcerer II Global Expedition, seminal work in cataloguing the human microbiome (all the microbes that live in and on the human body) and important research into a variety of infectious diseases and antibiotic resistance. These are just a few of the many research areas our team is tackling as we seek to make a worldwide impact with our science. For more than two decades Dr. J. Craig Venter and his research teams have been genomics pioneers. The revolution began in 1991 when at the National Institutes of Health Dr. Venter and his team developed expressed sequence tags (ESTs), a new technique to rapidly discover genes. In 1992 this team left NIH to start a new kind of not-for-profit research institute, The Institute for Genomic Research (TIGR). With the freedom to pursue any number of exciting avenues in the burgeoning field of genomics, the team used their new computing and computational tools, as well as new DNA sequencing technology, to sequence the first free living organism, Haemophilus influenzae in 1995. With this advance, the floodgates of genomics were opened. TIGR went on to sequence and analyze more than 50 microbial genomes. Dr. Venter and some from his team moved into mammalian genomics which culminated in the sequencing and analysis of the first draft human genome which was published in 2001 by Dr. Venter and his team at Celera Genomics.